Dizal: Voluntary disclosure of the announcement regarding Gao Ruizhe (Golecitinib capsules) obtaining approval from the National Medical Products Administration for listing.

SZSI · Jun 20

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.